Novocure Ltd (NVCR)

[dstock07734]

https://www.oncovir.com/about
Andres Salazar owns a family business which has the patent of poly-iclc, an essential ingredient for maximizing the efficacy of DCVax-L.

Here is the ongoing clinical trial which has Oncovir has one of the collaborators along with Merck.
https://classic.clinicaltrials.gov/ct2/show/NCT04201873?cond=atl-dc&draw=2&rank=1

Check the newly hired employees of Oncovir. They are high-caliber professionals and they don't join a company which has no future. Keep in mind that Oncovir was involved in over 70 clinical trials and none of them were successful. Its old patent of poly-iclc expired in July. But he filed for new patents already. Would you file a new patent and hire new employees if your product in the past 20 years didn't deliver not a single success?